CAMBRIDGE (CBS) — Moderna says its vaccine is 96% effective in protecting kids between 12 and 17 years old against COVID-19. That data is from a study of more than 3,2000 participants who received at least one dose of the vaccine.

The Cambridge-based biotech company also said none of the participants had severe reactions to the first or to the second shot.

READ MORE: 3 Dead In Olde Town Arvada Shooting, Including Arvada Police Officer Gordon Beesley, 1 Civilian, 1 Suspect

“No serious safety concerns have been identified to date,” Moderna said about the trial on teens.

READ MORE: 'Monumental Day': Jeremy Bloom Reacts To Supreme Court Ruling On Student-Athlete Payments

Moderna said another study of the vaccine on children 6 months to 11 years old is ongoing but didn’t give further details.

MORE NEWS: 40% Of Colorado COVID Cases Are New, More Transmissible Delta Variant, Health Officials Say

Earlier this week Moderna, which is expanding its manufacturing plant and lab in Norwood, said a third vaccine booster dose it developed shows it works against the more contagious South African and Brazilian variants.